Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Shranjeno v:
| Korporativna značnica: | |
|---|---|
| Drugi avtorji: | |
| Format: | Elektronski eKnjiga |
| Jezik: | English |
| Izdano: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Izdaja: | 1st ed. 2011. |
| Serija: | Current Topics in Microbiology and Immunology,
344 |
| Teme: | |
| Online dostop: | https://doi.org/10.1007/978-3-642-14136-2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!